相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Role of Colistin in the Era of New β-Lactam/β-Lactamase Inhibitor Combinations
Abdullah Tarik Aslan et al.
ANTIBIOTICS-BASEL (2022)
Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection: A Meta-Analysis
Chienhsiu Huang et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Clinical Efficacy and Nephrotoxicity of Colistin Alone versus Colistin Plus Vancomycin in Critically Ill Patients Infected with Carbapenem-Resistant Acinetobacter baumannii: A Propensity Score-Matched Analysis
Wasan Katip et al.
PHARMACEUTICS (2021)
The effectiveness and nephrotoxicity of loading dose colistin combined with or without meropenem for the treatment of carbapenem-resistant A. baumannii
Wasan Katip et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-ResistantAcinetobacter baumanniiUsing the Broth Microdilution Checkerboard and Time-Kill Methods
Vipavee Rodjun et al.
ANTIBIOTICS-BASEL (2020)
Pharmacokinetics and Penetration of Sitafloxacin into Alveolar Epithelial Lining Fluid in Critically III Thai Patients with Pneumonia
Taniya Paiboonvong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Clostridium difficile Infection Risk with Important Antibiotic Classes: An Analysis of the FDA Adverse Event Reporting System
Chengwen Teng et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2019)
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
Mical Paul et al.
LANCET INFECTIOUS DISEASES (2018)
Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features
Saad B. Almasaudi
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2018)
Colistin versus Colistin Combined with Ampicillin-Sulbactam for Multiresistant Acinetobacter baumannii Ventilator-associated Pneumonia Treatment: An Open-label Prospective Study
Demosthenes Makris et al.
INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2018)
Preliminary Clinical Study of the Effect of Ascorbic Acid on Colistin-Associated Nephrotoxicity
Rujipas Sirijatuphat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Comparative in vitro activity of sitafloxacin against bacteremic isolates of carbapenem resistant Acinetobacter baumannii complex
Yu-Shan Huang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2015)
Preliminary Study of Colistin versus Colistin plus Fosfomycin for Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections
Rujipas Sirijatuphat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
Emanuele Durante-Mangoni et al.
CLINICAL INFECTIOUS DISEASES (2013)
In vitro activity of sitafloxacin against carbapenem-resistant Acinetobacter baumannii
Visanu Thamlikitkul et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Population pharmacokinetics and pharmacodynamics of sitafloxacin in patients with community-acquired respiratory tract infections
Yusuke Tanigawara et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2013)
'Old' antibiotics for emerging multidrug-resistant bacteria
Phillip J. Bergen et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2012)
Sitafloxacin In Bacterial Infections
Gillian M. Keating
DRUGS (2011)
Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand
Pornpan Koomanachai et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2007)
Pharmacokinetics and absolute bioavailability of sitafloxacin, a new fluoroquinolone antibiotic, in healthy male and female Caucasian subjects
J O'Grady et al.
XENOBIOTICA (2001)
分享论文
